Details:
The candidate mRNA vaccine ‘BANCOVID’ is a LNP–encapsulated, nucleoside-modified mRNA–based vaccine that encodes the SARS-CoV-2 spike (S) glycoprotein stabilized in its prefusion conformation.
Lead Product(s): D614G variant LNP-encapsulated mRNA
Therapeutic Area: Infections and Infectious Diseases Product Name: Bancovid
Highest Development Status: Preclinical Product Type: Vaccine
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable September 30, 2020